Parker Pharma Pty Limited

Status: Registered
Australian Company Number: 150976542
Australian Business Number: 99150976542
Registration date: 2011-05-18
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Parker Pharma Pty Limited is a limited by shares, Australian proprietary company. This corporation was registered on 2011-05-18 and was issued with the 150976542 ACN. Its Australian Business Number is 99150976542. Since 2014-09-17, the company is headquartered in NSW, post code 2107. The previous headquarters were located in NSW 2107 (from 2012-07-08 to 2014-09-17), NSW 2107 (from 2011-05-18 to 2012-07-08). Parker Pharma Pty Limited was registered for the GST on 2011-05-18, up until 2013-03-31. The above data comes from the ABN database which was updated on 2021-10-15.

Details for ABN 99150976542

Type: Australian Private Company

ABN Status

Status From To
Cancelled 2021-10-15 current
Active 2011-05-18 2021-10-15

Main Name

Name From To
Parker Pharma Pty Limited 2011-05-18 current

Main Location

Location From To
NSW 2107 2014-09-17 current
NSW 2107 2012-07-08 2014-09-17
NSW 2107 2011-05-18 2012-07-08

Goods & Services Tax (GST)

Status From To
Registered 2011-05-18 2013-03-31

Advertisements

Find company

NSW 2107 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.